Point dose variations with time during traditional brachytherapy for cervical carcinoma

Gwendolyn C. King, William D. Bloomer, Shalom Kalnicki, Clare M. Faul, William E. Gooding, Todd F. Stockstill, Andrew Wu, Roy Buchsbaum, Alex S. Chen, Kristina Gerszten, Andre Kalend

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


In traditional brachytherapy for carcinoma of the cervix, doses are often prescribed to specifically chosen points (A and B) and the normal tissue tolerance calculated at specific reference points in the bladder and rectum. These tolerance doses are often used to modify the brachytherapy treatment plan. It is inherently assumed that the position of the brachytherapy applicator does not change in relation to the relevant anatomical structures over the time-course of an implant. To assess the accuracy of this assumption, 2 sets of localization films were obtained for each implant in 28 patients, 1 prior to loading and another after the removal of the radioactive sources. Significant applicator movement and, consequently, significant dose variations were observed. Therefore, isolated one-time dose measurements to normal critical structures should not be used as the sole basis for making therapeutic decisions. The magnitude of dose variations and their clinical significant are discussed. (C) 2000 American Association of Medical Dosimetrists.

Original languageEnglish (US)
Pages (from-to)77-80
Number of pages4
JournalMedical Dosimetry
Issue number2
StatePublished - Mar 2000
Externally publishedYes


  • Bladder
  • Brachytherapy
  • Carcinoma of uterus
  • Cervix
  • Dosimetry
  • Rectum

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Oncology
  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Point dose variations with time during traditional brachytherapy for cervical carcinoma'. Together they form a unique fingerprint.

Cite this